BayMedica Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

BayMedica General Information


Developer of a biosynthetic platform designed to provide a portfolio of natural cannabinoids for life science industry. The company's platform focus on biopharmaceuticals which are made of both naturally occurring and novel pharmaceutical-grade cannabinoids, enabling pharmaceutical manufacturers with an effective alternative than that of plant-derived cannabinoids.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • P.O. Box 8880
  • Suite 802-433
  • Incline Village, NV 89450
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BayMedica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view BayMedica’s complete valuation and funding history, request access »

BayMedica Executive Team (3)

Name Title Board Seat Contact Info
Charles Marlowe Ph.D Co-Founder & Director of Chemistry
Shane Johnson MD Co-Founder, President & Chief Executive Officer
Philip Barr Ph.D Co-Founder & Chief Scientific Officer
To view BayMedica’s complete executive team members history, request access »

BayMedica Board Members (2)

Name Representing Role Since
Gil Labrucherie JD Self Board Member 000 0000
Shane Johnson MD Self Co-Founder, President & Chief Executive Officer 000 0000
To view BayMedica’s complete board members history, request access »

BayMedica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xandex Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view BayMedica’s complete investors history, request access »